Ocular Therapeutix
OCUL
#5312
Rank
A$2.11 B
Marketcap
A$9.73
Share price
-1.57%
Change (1 day)
-14.17%
Change (1 year)

Earnings for Ocular Therapeutix (OCUL)

Earnings in 2024: -A$0.28 Billion

According to Ocular Therapeutix's latest financial reports the company's current earnings are A$55.78 Million. In 2024 the company made an earning of -A$0.28 Billion a decrease over its 2023 earnings that were of -A$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ocular Therapeutix from 2013 to 2024

Annual earnings

Year Earnings Change
2024-A$0.28 Billion139.68%
2023-A$0.12 Billion13.65%
2022-A$0.11 Billion984.05%
2021-A$9.27 Million-95.79%
2020-A$0.23 Billion80.19%
2019-A$0.13 Billion44.01%
2018-A$84.8 Million-5.38%
2017-A$89.62 Million41.79%
2016-A$63.21 Million12.47%
2015-A$56.2 Million38.75%
2014-A$40.51 Million115.12%
2013-A$18.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
SurModics
SRDX
-A$15.85 Million-95.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
A$18.4 M-105.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Intersect ENT
XENT
-A$0.23 Billion-35.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
A$0.34 B-197.22%๐Ÿ‡บ๐Ÿ‡ธ USA